Skip to main content
ARCT logo

ARCT · Arcturus Therapeutics Holdings Inc.

$5.97 -0.08 (-1.32%) At close · Jul 20
Market Cap
$169.69M
Shares
28.42M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Joseph Payne $1,691,000
Andy Sassine $1,181,500
Padmanabh Chivukula $862,000
Lance Kurata $830,000
Joe Roberts $273,580
Fiscal 2024
Executive Total
Joseph Payne $3,697,000
Andy Sassine $1,618,000
Padmanabh Chivukula $1,585,000
Lance Kurata $1,487,000
Joe Roberts $405,729
Fiscal 2023
Executive Total
Joseph Payne $4,892,500
Padmanabh Chivukula $3,178,500
Andy Sassine $2,182,500
Lance Kurata $2,095,000
Joe Roberts $347,874
Fiscal 2022
Executive Total
Joseph Payne $5,594,000
Andy Sassine $3,145,375
Padmanabh Chivukula $3,106,000
Lance Kurata $1,182,000
Fiscal 2021
Executive Total
Joseph Payne $960,000
Padmanabh Chivukula $750,000
Andy Sassine $750,000
Dr. Steven Hughes $644,000
Lance Kurata $560,000
Fiscal 2020
Executive Total
Joseph Payne $12,861,500
Andy Sassine $7,654,800
Padmanabh Chivukula $7,472,600
Lance Kurata $5,140,550
Dr. Steven Hughes $4,876,625
Fiscal 2019
Executive Total
Andy Sassine $1,326,880
Joseph Payne $1,165,818
Padmanabh Chivukula $636,156
Dr. Steven Hughes $299,873
Fiscal 2018
Executive Total
Joseph Payne $2,687,044
Padmanabh Chivukula $1,372,905
Andy Sassine $246,340

Executive changes

Person Change Filed
Dennis Mulroy Appointed 2026-05-07
Key facts CIK 1768224 CUSIP 03969T109 13F (30d) 10 filings 10 filers Visit website Investor relations